← Eichor
Condition: Neuroblastoma Nb Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Neuroblastoma Nb

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors
Phase 1/Phase 2 · 3 location(s) · Sun Yat-Sen University Cancer Center · NCT06836505A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06057948Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma
Phase 1 · 1 location(s) · Marzieh Ebrahimi · NCT06674265Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Ris
Phase 3 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT07375563Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis
Phase N/A · 1 location(s) · Nanjing First Hospital, Nanjing Medical University · NCT07064746Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07318831
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.